John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 10,000 shares at $54.89 ($549K) on 2023-06-05, disclosed to the SEC on 2023-06-07.
Seasonal sale ($549k) by Director — this insider has traded TXG in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |
| TXG | SELL | 2021-11-18 | $1.6M | — | Filing → |